Please login to the form below

Not currently logged in
Email:
Password:

real-world evidence

This page shows the latest real-world evidence news and features for those working in and with pharma, biotech and healthcare.

FDA and Flatiron extend real world evidence collaboration

FDA and Flatiron extend real world evidence collaboration

Roche-owned specialists at forefront of big data analysis. The FDA is pushing ahead with efforts to integrate real world evidence (RWE) into its regulatory decision-making, and has an unveiled ... At the end of the day, this is how we're closing the

Latest news

  • Greater Manchester backs move to outcome-based payment Greater Manchester backs move to outcome-based payment

    Also of central importance is the need to build robust data collection and real world evidence systems. ... While the UK is already among the top countries in the world in making new cancer medicines available to patients, it’s vital for patients and

  • IQVIA sees market slowdown looming for pharma IQVIA sees market slowdown looming for pharma

    It also predicts an increase in the use of artificial intelligence in drug discovery and development, rising numbers of mobile apps submitted for FDA approval, and further emergence of real-world ... evidence (RWE) within clinical development.

  • Beneluxa: the future of European market access? Beneluxa: the future of European market access?

    As the collection of real-world evidence (RWE) is part of the Spinraza agreement, I ask whether or not this will become standard in the future – and hand in hand with ... One prerequisite for a shift towards an outcomes-based reimbursement model is of

  • UK’s genomics leadership attracts IQVIA investment, regardless of Brexit UK’s genomics leadership attracts IQVIA investment, regardless of Brexit

    owned Genomics England is to launch a collaboration to integrate its world-leading genomic database with IQVIA’s UK clinical trials capabilities, a key milestone in its development. ... and delivery of hundreds of additional clinical trials and

  • Abbott’s wearable glucose monitor to be available across England Abbott’s wearable glucose monitor to be available across England

    Years of clinical and real world evidence show that when people use this technology, they have both short and long term benefits to their diabetes control.  When Abbott set out to ... This will be based on previous national guidance issued- with the

More from news
Approximately 11 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • #OrkambiNow? #OrkambiNow?

    The answer is likely to lie, at least in part, in exploiting the UK’s CF disease registry to provide real-world evidence of the drugs’ effectiveness. ... It is also notable that the Cystic Fibrosis Trust’s suggestion of allowing interim access and

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    The partnership will aim to enable faster and more efficient drug research, generate more robust evidence to support treatment value, and ultimately provide greater access to personalised medicines. ... and real-world evidence studies.

  • Launch trends 2019 Launch trends 2019

    A key trend is increasing evidence needs, ie, having greater evidence to ensure reimbursement of high prices, even for orphan drugs. ... Market access is becoming more complex, with new requirements such as real-world evidence (RWE), conditional

  • Launch excellence: beyond the six-month mantra Launch excellence: beyond the six-month mantra

    Individualised medicine, real-world evidence and algorithmic prescribing are emerging challenges and opportunities that launch teams need to address – how each company responds to these depends on its own unique context,

  • Escaping the spin cycle of sub-optimal launch Escaping the spin cycle of sub-optimal launch

    Growing demand for real-world evidence and the drive towards individualised medicines are bringing new considerations to launch planning,” says Ed. ... In today’s world, new therapies are launching into much more complex markets than they did in the

More from intelligence
Approximately 8 fully matching, plus 48 partially matching documents found.

Latest appointments

  • Remi Gauchoux joins Carenity Remi Gauchoux joins Carenity

    Gauchoux has a 20-year international experience in healthcare and the CRO industries with expertise in late phase and real-world evidence analysis.

  • Dr Ameet Nathwani moves from Novartis to Sanofi Dr Ameet Nathwani moves from Novartis to Sanofi

    Oliver Brandicourt, Sanofi's chief executive officer, said: “Our industry is experiencing increased pressure to support reimbursement with customized data from real-world evidence, demonstrate ongoing benefit-risk of registered products

  • EMA's Dr Stella Blackburn joins Quintiles EMA's Dr Stella Blackburn joins Quintiles

    Cynthia Verst, president, real world and late phase research at Quintiles, said: “Stella's experience developing innovative risk management solutions is a tremendous addition to our team. ... She said: “Together with my colleagues at Quintiles, I aim

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics